AstraZeneca Pharma India Schedules August 19 Investor Meeting

Event Details

A one-on-one meeting with an institutional investor is scheduled to be held virtually on Wednesday, August 19, 2026.

Important Disclaimer

The document explicitly states that the announced dates are subject to change. Changes may occur due to exigencies on the part of the Company, the Analyst, or the Investor.

Company and Signatory

The disclosure is made by AstraZeneca Pharma India Limited. The letter is signed by Tanya Sanish, Company Secretary & Compliance Officer, and is digitally dated August 15, 2026.